Rising Patient Pool Resulting in an Increased Uptake of Embolic Protection Devices

The global embolic protection devices market is estimated to record a substantial CAGR of 8.0% during the forecast period (2021-2027). Cardiovascular and neurovascular diseases are recognized as the leading cause of fatality and disability across the globe. Coronary artery disease (CAD) and peripheral artery disease (PAD) are the leading cardiovascular diseases globally. Besides, saphenous vein graft (SVG) failure is also common in patients following coronary artery bypass graft (CABG) surgery for treating CAD. In addition, about 250,000 patients have symptomatic severe AS. Such rising disease burden is influencing the higher uptake of embolic protection devices during various percutaneous cardiac procedures, including PCI, atherectomy, TAVR, CAS, to reduce the number of complications caused by debris being released into the bloodstream due to the procedures and causing blockages in smaller vessels by capturing and removing them. Therefore, the growing prevalence of various cardiovascular and neurovascular diseases are significantly contributing to the growth of the global embolic protection devices market.

Browse the full report description of "Global Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/embolic-protection-devices-market

However, despite the success of embolic protection devices in many cardiovascular & peripheral and neurovascular applications, the clinical adoption of EPDs is still lagging compared to the expected penetration of the devices. In addition, the inadequate training of HCPs in LMICs regarding the latest surgical devices, infrastructure inadequacy, high procedural cost followed by poor reimbursement scenario are the major factors that can lead to the lesser uptake of modern embolic protection devices, which can limit the market growth.

Market Coverage

• Market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- by Product, Application, and End-user
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Embolic Protection Devices Market Report Segment

By Product 

• Filter Devices
• Occlusion Devices

By Application

• Cardiovascular & Peripheral
• Neurovascular

By End-user

• Ambulatory Surgery Centers
• Freestanding CATH Labs
• Hospitals
• Specialty Cardiac Centers

Global Embolic Protection Devices Market Report Segment

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/embolic-protection-devices-market